Other Stories

Study of 30,000 volunteers shows Novavax vaccine to be 93% effective against COVID-19 Updated: 2021-06-15 09:57:25 KST

Novavax says its COVID-19 vaccine is more than 90-pecent effective in a late-stage clinical trial.
The study was conducted on nearly 30-thousand volunteers in the U.S. and Mexico, showing overall efficacy of 90.4 percent.
The vaccine was also shown to be 93-percent effective against variants.
It also found the vaccine was 100-percent effective in preventing moderate and severe cases of the virus.
South Korea has so far secured 40 million Novovax doses, and will get up to 20 million more within the third quarter.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.